ID   Karpas-353
AC   CVCL_9553
SY   KARPAS-353; Karpas 353; KARPAS 353; K353
DR   Cosmic; 2297005
DR   GEO; GSM119483
DR   Progenetix; CVCL_9553
DR   Wikidata; Q54899497
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7849311;
RX   PubMed=8324225;
RX   PubMed=16960149;
RX   PubMed=26727417;
CC   Omics: Array-based CGH.
CC   Miscellaneous: Originally assigned to be from a B-cell acute lymphoblastic leukemia (ALL-L2).
CC   Derived from sampling site: Peripheral blood.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-10-20; Version: 13
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001).
//
RX   PubMed=7849311; DOI=10.1182/blood.V85.4.893.bloodjournal854893;
RA   Stranks G., Height S.E., Mitchell P., Jadayel D.M., Yuille M.A.R.,
RA   De Lord C., Clutterbuck R.D., Treleaven J.G., Powles R.L.,
RA   Nacheva E., Oscier D.G., Karpas A., Lenoir G.M., Smith S.D.,
RA   Millar J.L., Catovsky D., Dyer M.J.S.;
RT   "Deletions and rearrangement of CDKN2 in lymphoid malignancy.";
RL   Blood 85:893-901(1995).
//
RX   PubMed=8324225; DOI=10.1182/blood.V82.1.231.bloodjournal821231;
RA   Nacheva E., Dyer M.J.S., Fischer P., Stranks G., Heward J.M.,
RA   Marcus R.E., Grace C., Karpas A.;
RT   "C-MYC translocations in de novo B-cell lineage acute leukemias with
RT   t(14;18) (cell lines Karpas 231 and 353).";
RL   Blood 82:231-240(1993).
//
RX   PubMed=16960149; DOI=10.1182/blood-2006-06-026500;
RA   Mestre-Escorihuela C., Rubio-Moscardo F., Richter J.A., Siebert R.,
RA   Climent J., Fresquet V., Beltran E., Agirre X., Marugan I., Marin M.,
RA   Rosenwald A., Sugimoto K.-J., Wheat L.M., Karran E.L., Garcia J.F.,
RA   Sanchez L., Prosper F., Staudt L.M., Pinkel D., Dyer M.J.S.,
RA   Martinez-Climent J.A.;
RT   "Homozygous deletions localize novel tumor suppressor genes in B-cell
RT   lymphomas.";
RL   Blood 109:271-280(2007).
//
RX   PubMed=26727417; DOI=10.3109/10428194.2015.1108414;
RA   Drexler H.G., Eberth S., Nagel S., MacLeod R.A.F.;
RT   "Malignant hematopoietic cell lines: in vitro models for double-hit
RT   B-cell lymphomas.";
RL   Leuk. Lymphoma 57:1015-1020(2016).
//